Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Whitaker

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2016
Epipolymorphisms associated with the clinical outcome of autoimmune arthritis affect CD4+ T cell activation pathwaysRoberto Spreafico, Maura Rossetti, John W Whitaker, et al.
The Journal of Investigative Dermatology|July 17, 2021
Response to Marchetti et alDarrell S Rigel, John W Whitaker, Maral K Skelsey, et al.
Genome Medicine|May 2, 2013
An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotypeJohn W Whitaker, Robert Shoemaker, David L Boyle, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
The Rheumatoid Arthritis Risk Gene LBH Regulates Growth in Fibroblast-like SynoviocytesAnna-Karin H Ekwall, John W Whitaker, Deepa Hammaker, et al.
Environmental and Molecular Mutagenesis|July 15, 2009
Mutagen structure and transcriptional response: induction of distinct transcriptional profiles in Salmonella TA100 by the drinking-water mutagen MX and its homologuesWilliam O Ward, Carol D Swartz, Nancy M Hanley, et al.
Nucleic Acids Research|June 26, 2012
Global identification of transcriptional regulators of pluripotency and differentiation in embryonic stem cellsKyoung-Jae Won, Zheng Xu, Xian Zhang, et al.
Plos One|April 23, 2015
Integrative omics analysis of rheumatoid arthritis identifies non-obvious therapeutic targetsJohn W Whitaker, David L Boyle, Beatrix Bartok, et al.
Plos One|August 20, 2015
Correction: Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic TargetsJohn W Whitaker, David L Boyle, Beatrix Bartok, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2016
LBH Gene Transcription Regulation by the Interplay of an Enhancer Risk Allele and DNA Methylation in Rheumatoid ArthritisDeepa Hammaker, John W Whitaker, Keisuke Maeshima, et al.
Translational Psychiatry|June 19, 2026
Discovery of a potential novel pharmacogenomic biomarker on ANK3 gene for liafensine, a triple reuptake inhibitor for treatment-resistant depressionWen Luo, Gang Wang, John W Whitaker, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2016
Epipolymorphisms associated with the clinical outcome of autoimmune arthritis affect CD4+ T cell activation pathwaysRoberto Spreafico, Maura Rossetti, John W Whitaker, et al.
The Journal of Investigative Dermatology|July 17, 2021
Response to Marchetti et alDarrell S Rigel, John W Whitaker, Maral K Skelsey, et al.
Genome Medicine|May 2, 2013
An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotypeJohn W Whitaker, Robert Shoemaker, David L Boyle, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
The Rheumatoid Arthritis Risk Gene LBH Regulates Growth in Fibroblast-like SynoviocytesAnna-Karin H Ekwall, John W Whitaker, Deepa Hammaker, et al.
Environmental and Molecular Mutagenesis|July 15, 2009
Mutagen structure and transcriptional response: induction of distinct transcriptional profiles in Salmonella TA100 by the drinking-water mutagen MX and its homologuesWilliam O Ward, Carol D Swartz, Nancy M Hanley, et al.
Nucleic Acids Research|June 26, 2012
Global identification of transcriptional regulators of pluripotency and differentiation in embryonic stem cellsKyoung-Jae Won, Zheng Xu, Xian Zhang, et al.
Plos One|April 23, 2015
Integrative omics analysis of rheumatoid arthritis identifies non-obvious therapeutic targetsJohn W Whitaker, David L Boyle, Beatrix Bartok, et al.
Plos One|August 20, 2015
Correction: Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic TargetsJohn W Whitaker, David L Boyle, Beatrix Bartok, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2016
LBH Gene Transcription Regulation by the Interplay of an Enhancer Risk Allele and DNA Methylation in Rheumatoid ArthritisDeepa Hammaker, John W Whitaker, Keisuke Maeshima, et al.
Translational Psychiatry|June 19, 2026
Discovery of a potential novel pharmacogenomic biomarker on ANK3 gene for liafensine, a triple reuptake inhibitor for treatment-resistant depressionWen Luo, Gang Wang, John W Whitaker, et al.
Pageof 4